UCSF The Medical Management of AIDS and Key Infections 2023

Include: 39 videos 28 pdfs, size: 14.32 GB

The University of California, San Francisco (UCSF) presents The Medical Management of AIDS and Key Infections 2023, a three-day educational program providing comprehensive, evidence-based updates on HIV treatment and the management of major co-infections. Delivered by leading UCSF faculty and invited experts, the course blends lectures, case-based discussions, and interactive Q&A to translate cutting-edge research into practical bedside care.

What You Will Learn

• Current strategies in antiretroviral therapy (ART), including new long-acting regimens and resistance management

• Optimal use of HIV prevention methods such as PrEP, PEP, and DoxyPEP

• Diagnosis and treatment of common co-infections: hepatitis B and C, tuberculosis, syphilis, and other sexually transmitted infections

• Management of emerging respiratory infections, including influenza, RSV, and COVID-19, in people living with HIV

• Best practices for addressing comorbidities—cardiovascular, metabolic, renal, and neurologic—within HIV care

• Guidance for initial treatment of new patients and strategies for switching or simplifying ART in established patients

Event Details

• Dates: 2023 (specific session dates provided by UCSF CME office)

• Format: Hybrid — attend live in San Francisco or participate via high-quality livestream; session recordings are provided for later review

• Organizer: UCSF Division of HIV, Infectious Diseases & Global Medicine, Zuckerberg San Francisco General Hospital

Who Should Attend

• Physicians in infectious diseases, internal medicine, family medicine, and hospital medicine who care for patients with HIV or complex infections

• Nurse practitioners, physician assistants, pharmacists, and nurses involved in HIV management or prevention

• Clinicians in community health centers or global health programs seeking the latest updates in HIV and infectious diseases

Why Attend

• Gain the most up-to-date, guideline-based recommendations for HIV prevention and treatment

• Learn practical, case-based approaches that can be immediately applied in clinics, hospitals, and community settings

• Expand your professional network with leading HIV and infectious disease experts

• Stay ahead of emerging trends in infectious disease management and multidisciplinary care

Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Day 1 – Thursday, December 14, 2023

Theme: State of HIV & Antiretroviral Therapy (ART)

• Morning Plenary: Top Ten Issues in HIV Medicine, HIV cure advances, and AI in clinical medicine.

• HIV Prevention Focus: Cutting-edge prevention strategies, PEP, PrEP & DoxyPEP case discussions.

• Afternoon ART Updates: State of the Art of ART, cardiology & cardiac prevention insights, and a lively ART management debate.

• Infectious Complications: Real-world HIV and STI case presentations, with up-to-date STI management strategies.

• Optional Workshop: ART101 – from guidelines to practice.

Day 2 – Friday, December 15, 2023

Theme: RSV, Flu, COVID-19, Hepatitis, and Endocrine & Reproductive Health

• Respiratory & COVID-19 Updates: Latest on RSV, flu, MPOX, outpatient COVID treatment, and long COVID management.

• Liver Care Focus: Advances in hepatitis B, NAFLD/NASH, and cirrhosis, with interactive panels.

• Afternoon Highlights: Updates on endocrinology, sexual & reproductive health in HIV, and tuberculosis.

• Parallel Workshops: New Clinicians’ Track on ARV resistance and opportunistic infections, plus infectious-disease pearls and clinical imaging cases.

Day 3 – Saturday, December 16, 2023

Theme: Optimizing HIV Patient Care & Multisystem Updates

• Morning Sessions: Weight management, STI case discussions, and critical insights on substance use trends and addiction medicine.

• Mental Health Focus: Managing complex PTSD and cognitive concerns.

• Afternoon Updates: ART management panel, pulmonary topics like asthma, COPD, and PFT interpretation, and HIV dermatology cases.